About the
Award

The Tom Reeve Award  for Outstanding Contributions to Cancer Care, offered annually by COSA, formally recognises a national leader who has made significant contributions to cancer care.

The successful nominee will be presented with a Gold Marryalyan at the COSA Annual Scientific Meeting where they will be invited to deliver an address highlighting appropriate aspects of their area of professional interest.

Nominations are now open for the 2022 Tom Reeve Award for Outstanding Contributions to Cancer Care, closing Monday 1 August 2022.

2021 Tomreeve Michaelbarton

Award eligibility & criteria

- have made significant contributions to cancer care through research, clinical leadership and/or community service
- have made substantial contributions over a relatively long period of time
- be nominated by a COSA member and have support from a member of COSA Council
- be an Australian resident

- an explanation of the nominee’s work in the area of cancer control or research
- an evaluation of the accomplishments of the nominee
- letters of reference from two individuals from outside the nominees’ institution (where applicable). These letters should contain a critical appraisal of the nominee’s work

Download the 2022 Tom Reeve Award Nomination form

Nominations and supporting documentation should be sent to cosa@cancer.org.au by COB Monday 1 August 2022.

Award recipients

One of Professor Barton's nominators said: “As a pioneer of academic radiation oncology in Australia, Michael has made, and is still making, outstanding contributions to clinical care, in oncological research, and cancer services policy throughout his career. He would be a very worthy recipient of the Tom Reeve Award.” And the COSA Board agrees.

Professor Barton will be well known to the COSA community. He is a clinical academic specialist Radiation Oncology at Liverpool Hospital, Cancer Therapy Centre and Research Director of the Collaboration for Cancer Outcomes Research and Evaluation (CCORE), who has dedicated his lifetime’s work to the improvement and innovation in the field of radiation oncology and cancer care.

Michael’s greatest contribution to radiation oncology in Australia and internationally may be considered his work in providing the evidence on which to base health policy and advising governments on frameworks for cancer services and then evaluating the impact of those services. A pivotal study was the determination from evidence-based treatment guidelines of the percentage of cancer patients who should receive radiation therapy at some time in their treatment, which enabled planning of radiation services.

Throughout his career he has mentored, educated and researched all the while providing excellent, team-based clinical care. This has provided an environment that has brought on another generation of researchers and provided clinical care in the more resource-challenged areas of Greater Sydney.

Michael initiated the Basic Science in Oncology Course (BSOC) which has continued to grow and thrive since its inception in the early 1990’s. Countless clinicians from a range of oncology and palliative care backgrounds have benefited from this work. Most recently, he brought together the three cancer streams through the Translational Cancer Research Centres (TCRC) at the University of New South Wales into a cohesive team working closely together on research and translation of research into clinical care.

Michael has written 42 commissioned reports for a wide variety of agencies on the delivery plans for various health jurisdictions, including the International Atomic Energy Agency (IAEA), the World Health Organisation (WHO), and the Global Taskforce for the use of Radiotherapy for Cancer Control (GTFRCC), an international collaboration to advise and plan for expansion of radiotherapy facilities around the world to better cater for the cancer needs of every country, especially those countries with serious health service delivery deficits. He chaired the Australian guidelines for the management of Adult Gliomas.

In terms of individual research output, as Research Director of CCORE he has been awarded over $20M in peer-reviewed funding. He has published 200 original scientific papers in peer-reviewed journals, 43 published abstracts, 9 editorials, 2 books, 15 book chapters, 8 electronic publications, and has over 9048 citation and an h-index of 46.

And the list goes on!

Professor Barton OAM was presented with the Tom Reeve Award and delivered his oration, during the 2021 COSA ASM on Wednesday 17 November. The presentation and oration are available for ASM delegates to view as recorded content.

Professor, Translational Cancer Research, Director, Sansom Institute for Health Research
Dean, Research Strategy, Division of Health Sciences, University of South Australia

Executive Director, Victorian Comprehensive Cancer Centre

COSA President 1992-93

COSA President 2021-22 
Medical Oncologist, North Sydney’s Mater Hospital
Director of the Patricia Ritchie Centre for Cancer Care and Research
Professor of Medical Oncology, University of Sydney 

COSA President 2006-June 2006
Professor, Palliative and Supportive Services, Flinders University
Chief Cancer Officer, New South Wales
Chief Executive Officer, Cancer Institute of New South Wales

COSA President 2000-01
Professor, Palliative and Supportive Services, Flinders University
Chief Cancer Officer, New South Wales
Chief Executive Officer, Cancer Institute of New South Wales

Chief Executive Officer and Director of Research, Translational Research Institute

Chair of Lung Cancer Service, Peter MacCallum Cancer Centre

COSA President 2017-18
Director of the Medical Psychology Research Unit, The University of Sydney

Professor of Surgical Oncology, University of Newcastle

Director of Research, School of Nursing and Midwifery, Queensland University of Technology

Professor of Radiology, University or Melbourne

COSA President 1981-83
Professor of Cancer Medicine, The University of Sydney

COSA President 1994-95
Chief Executive Officer, Cancer Council Australia

Executive Officer, the Australian Cancer Network

About Emeritus Professor
Tom Reeve AC CBE

Professor Tom Reeve AC CBE is Emeritus Professor in Surgery of the University of Sydney where he graduated in 1947. After working in Sydney and Queensland, he trained in General and Thoracic Surgery at Albany Medical College, New York. In 1958, the American Board of Surgery certified Professor Reeve and he became a Fellow of the Royal Australasian College of Surgeons in 1967. He was Chairman of Surgery at The University of Sydney from 1982-1988 and chaired the Northern Sydney Health Area from 1988-1996.

On retirement, Professor Reeve became President of the Royal Australasian College of Surgeons and Executive Officer of the Australian Cancer Network. In this role, Professor Reeve was involved in the development of Clinical Guidelines for the Management of Early Breast Cancer, the first evidence-based cancer management guidelines produced in Australia 

Tom Reeve